SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
DiamondRock Hospitality Co released an investor presentation highlighting its differentiated earnings growth, disciplined capital allocation, and leveraging of portfolio optionalit…
Company appoints veteran finance executive Hamid Shekarchi to lead finance function as Interim CFO, effective immediately.
Middleby Corp updated investors on its operations and business outlook during a presentation at the Jefferies Industrials Conference in New York on September 10, 2026.
Lipocine management will present at the H.C. Wainwright conference in September 2026. This event highlights the company's pipeline and upcoming clinical progress, potentially offer…
Trilogy Metals Inc. received a 2026 TSX30 ranking, up 570% over three years, driven by the strategic importance of the Upper Kobuk Mineral Projects in northwest Alaska.
Wrap Technologies Inc. has amended and restated the employment agreement of CEO and Executive Chairman Scot Cohen, effective Sept. 2, 2026. The changes include revisions to his tit…
Candel Therapeutics filed an updated corporate presentation to reflect its strategy of tipping the immune system to fight cancer, outlining perspectives for current and future rese…
Upexi Chief Strategy Officer Brian Rudick will attend the FT Partners FinTech Conference in New York, indicating management's continued engagement with the financial investor commu…
OS Therapies Inc. filed an Amended and Restated 2023 Incentive Compensation Plan with the SEC, outlining terms for stock-based awards to employees and executives.
Essential Properties Realty Trust executed an Amended & Restated Employment Agreement with Peter M. Mavoides, extending his service term and updating compensation details.
Castellum, Inc. President and CEO Glen Ives and CFO David Bell will present at the H.C. Wainwright Global Investment Conference on Sept. 15. Management will also be available for o…
BDO USA, P.C. filed a response to Lee Enterprises' Form 8-K, agreeing with the statements on its own firm for the September 2, 2026, event. This indicates the engagement of a major…
CME Group promoted Jack Tobin to CFO and John Marchese to General Counsel, effective March 2027, as Lynne Fitzpatrick transitions to CEO. This strategic leadership reshuffle reinfo…
Skyline Bankshares announced Carl Eickhorst will assume additional duties as CEO, potentially streamlining operations and overseeing a broader scope of corporate activities.
Vivmark Residential announced CEO Benjamin W. Schall will present at the Bank of America Global Real Estate Conference, highlighting ongoing business metrics and future outlook.
Cornerstone Building Brands announced Matthew Garth will serve as CFO starting Sept. 2026. Garth brings 30+ years of experience from Dentsply Sirona and The Scotts Miracle-Gro. Thi…
GPC named Court Carruthers as its new Executive Vice Chairman, who will become CEO-Elect of the Automotive business on September 8, 2026, with compensation detailed in an employmen…
Xeris Biopharma Holdings outlined the clinical development roadmap for its thyroid treatment XP-8121, including a potential for peak revenues of $1 billion to $3 billion, while ant…
ElectroCore filed a mark-up and restatement of its Third Amended and Restated Bylaws, updating foundational corporate governance parameters.
Turn Therapeutics named former CDC head Dr. Robert Redfield its Chief Scientific Officer to oversee clinical strategy, following interim data for its GX-03 treatment.